MRM Health and Biocodex Partner on €15 Million Manufacturing Facility for Microbiome-Based Medicines

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration c...

November 06, 2026 | Friday | News
Link Biologics Completes Preclinical Studies for LB001 Dry Eye Disease Treatment Ahead of 2027 Clinical Trials

Completion of key IND-enabling activities represents a major development milestone for LB001 IND submission remains on track for Q1 2027, followed by in...

November 06, 2026 | Friday | News
ArrayPatch Raises €3.2 Million in Seed Funding to Advance Microneedle Patch Treatments for Obesity and Cancer

ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of t...

November 06, 2026 | Friday | News
Ethris Reports 40-Fold Reduction in Viral Load in Phase 2a Trial of ETH47 for Asthma

40-fold lower virus load compared to placebo on Day 2, at the peak of viral replication Exposure-response relationship observed, with greater interferon l...

November 06, 2026 | Friday | News
Gesynta Pharma Advances Non-Hormonal Endometriosis Treatment Vipoglanstat Following Early Phase 2 Trial Enrolment

For millions of women living with endometriosis, persistent pain can disrupt daily life, affect fertility and limit treatment choices. Existing hormonal th...

November 05, 2026 | Thursday | Interaction
Minghui Pharmaceutical and ASKA Sign Potential US$440 Million Licensing Deal for Thyroid Eye Disease Drug in Japan

Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") announced that they have entered into an exclusive license agreement for the ...

November 05, 2026 | Thursday | News
AbbVie and Nxera Pharma Sign Potential US$1.47 Billion Licensing Deal for Inflammatory Bowel Disease Drug

Nxera to receive US$100 million upfront and be eligible for up to US$1.37 billion in development and commercial milestone payments, plus tiered royalties...

November 05, 2026 | Thursday | News
Boehringer Ingelheim and Sino Biopharmaceutical Sign Potential US$7.36 Billion Oncology Licensing Deal

Partnership provides opportunities to further expand Boehringer Ingelheim’s portfolio of antibody-drug conjugates (ADCs) and T-cell engagers (TcEs)...

November 05, 2026 | Thursday | News
China Medical System Secures Singapore Approval for Lumirix Cream to Treat Vitiligo

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Rxilient Medical received ...

November 05, 2026 | Thursday | News
Blackstone Life Sciences and Boston Scientific Announce US$455 Million Collaboration to Develop VITALYST Heart Pump

Blackstone Life Sciences (“BXLS”) announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the developm...

November 04, 2026 | Wednesday | News
Rhythm Pharmaceuticals Secures US$750 Million Financing and Amends LG Chem Obesity Drug Licensing Agreement

Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon a...

November 04, 2026 | Wednesday | News
OraSure Technologies Joins World Coalition on Sickle Cell Disease to Improve Early Diagnosis and Access to Care

OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic tests and sample management solutions, announced that it has joined the Wo...

November 03, 2026 | Tuesday | News
Heartflow Reports CT-Guided PCI Matches IVUS Outcomes with Shorter Procedures in 1,105-Patient P4 Trial

Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrat...

November 03, 2026 | Tuesday | News
Bracco Brings Together 14 Global Experts to Advance Contrast-Enhanced Ultrasound Research and Clinical Applications

Bracco convened the second edition of the Global CEUS Steering Committee, bringing together international experts in contrast-enhanced ultrasound (CEUS) to...

November 03, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close